Results for Surgical Models

1 - 10 of 48

Dr. Flake is a general pediatric surgeon with a clinical and research focus on prenatal treatment ranging from the fetal surgical repair of anatomic anomalies to prenatal stem cell and gene therapy. He has extensive experience in developing rodent, canine, and sheep models for in utero transplantation and for investigating fetal surgery for anatomic malformations.

E-mail:

flake [at] chop.edu

Geary "Chip" Smith, DVM, MS

Dr. Smith is a laboratory animal medicine veterinarian. As Technical Director of the CCMT Comparative Medicine Services Core, he helps guide promising therapeutics and devices from discovery and developmental studies through nonclinical studies.

E-mail:

smithgr [at] chop.edu

Eric Chien-Wei Liao, MD, PhD

Dr. Liao is a pediatric plastic surgeon-scientist and the founding director of the Center for Craniofacial Innovation at Children's Hospital of Philadelphia. His research leverages convergent advances in fetal care, human genetics, and developmental biology to initiate first-in-child trials and treatments.

E-mail:

liaoce [at] chop.edu

Patrick J. Cahill, MD

Dr. Cahill's focuses on improving treatments for patients with early onset chest and spinal deformity, employing a combination of clinical, biomechanical, and basic science research approaches.

E-mail:

cahillp1 [at] chop.edu

Charles A. Stanley, MD

Dr. Stanley’s lab has identified many of the genes and syndromes associated with congenital hyperinsulinism including ABCC8, GCK, GLUD1, and Turner and Beckwith syndromes. Working with clinical and rodent model studies, his lab team has identified distinctive phenotypes of these disorders, including diazoxide unresponsiveness, leucine sensitivity, and protein sensitivity. Dr. Stanley continues to seek new diagnostic and treatment paradigms for infants with acquired and genetic disorders of hyperinsulinism.

E-mail:

stanleyc [at] chop.edu

Diva D. De León-Crutchlow, MD, MSCE

Dr. De Leon-Crutchlow’s translational research program focuses on examining the pathophysiology of disorders of insulin regulation, identifying novel therapeutic targets, and developing new therapies for these conditions. The program approach includes patient-oriented research and bench research employing mouse models and primary islet cultures.

E-mail:

deleon [at] chop.edu

Matthew A. Jolley, MD

Dr. Jolley's research lab is focused on visualizing and quantifying congenitally abnormal heart structures using 3D imaging with the driving goal of informing surgical and interventional planning in children and adults with congenital heart disease.

E-mail:

jolleym [at] chop.edu